Robert Thomas Acquires 450,000 Shares of Starpharma (ASX:SPL) Stock

Starpharma Holdings Limited (ASX:SPL) insider Robert Thomas purchased 450,000 shares of the business’s stock in a transaction that occurred on Thursday, October 16th. The shares were purchased at an average cost of A$0.28 per share, with a total value of A$125,550.00.

Starpharma Stock Performance

The firm has a market capitalization of $43.90 million, a PE ratio of -5.25 and a beta of 0.77. The company has a debt-to-equity ratio of 12.55, a quick ratio of 5.65 and a current ratio of 4.94.

Starpharma Company Profile

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.